 A drug discovery company with ownership stakes in several public and private biopharmaceutical companies is going public with a SPAC deal announced Monday morning. The SPAC Deal: Roviant Sciences announced a SPAC deal with Montes Archimedes Acquisition Corp NASDAQ: MAAC. 